Wallachbeth capital announces pricing of bone biologics $5,100,000 underwritten public offering

Jersey city, n.j. , oct. 7, 2022 /prnewswire/ -- wallachbeth capital llc, a leading provider of capital markets and institutional execution services, announced today that bone biologics corporation (nasdaq: bblg), a developer of orthobiologic products for spine fusion, announced the pricing of an underwritten public offering of 3,777,778 units at an offering price of $1.35 per unit, for total gross proceeds of $5,100,000 before deducting underwriting discounts and commissions and other offering expenses.
BBLG Ratings Summary
BBLG Quant Ranking